Metabolic Syndrome and Obesity Raise Breast Cancer Risk
July 1, 2024 / Breast Cancer Risk / Metabolic Syndrome / Obesity
A study indicates metabolic syndrome (MetS) and obesity raise breast cancer risk in distinct ways, emphasizing MetS as a significant predictor of poor prognosis and higher mortality in postmenopausal women.
New BMI rules in England could mean millions more are classed as ‘obese’
July 8, 2024 / BMI Guidelines / Obesity / Weight loss / England
New BMI guidelines in England may classify more people as obese, allowing millions to access weight loss jabs on the NHS. The proposed criteria include a BMI over 25 and a waist-to-height ratio above 0.5.
Semaglutide and very-low calorie diet combo shows superior results in managing type 2 diabetes agonists for MASLD
July 8, 2024 / Semaglutide / Low-calorie Diet / Type 2 Diabetes / Weight Loss
A study by the University of Nottingham found that combining a very low-calorie diet with Semaglutide significantly improves weight loss and blood glucose control in type 2 diabetes patients more effectively than either intervention alone.
The therapeutic potential of irisin to mitigate the risk of metabolic syndrome in postmenopausal women
July 7, 2024 / Irisin Benefits / Metabolic Syndrome / Postmeopausal Health
Irisin, an exercise-inducible myokine, shows promise in mitigating metabolic syndrome in postmenopausal women by addressing conditions like obesity, insulin resistance, and hypertension, offering a potential alternative to long-term hormone replacement therapy.
Ghee, coconut oil can aggravate fatty liver
July 7, 2024 / Fatty Liver Disease / Non-Alcoholic Fatty Liver
Ghee and coconut oil may aggravate fatty liver disease, a condition marked by fat accumulation in liver cells, influenced by alcohol, obesity, and metabolic syndrome, potentially leading to liver inflammation and damage.
Obesity, abdominal obesity, metabolic obesity phenotypes, and Helicobacter pylori infection: results from NHANES 1999–2000
July 1, 2024 / Obesity / Abdominal obesity / WHtR / Metabolic Obesity
A study using NHANES 1999–2000 data found that abdominal obesity, defined by waist-height ratio (WHtR), is significantly associated with Helicobacter pylori infection, especially in individuals under 50 years, while general obesity (BMI) shows no association.
New insights into metabolic and immune pathway interactions in obesity
July 5, 2024 / Obesity / Metabolic Pathways / Immune Response
Research reveals that TBC1D1 and Rab8a regulate ROS production in macrophages, influencing inflammation and obesity. This study highlights potential therapeutic targets for obesity and related metabolic disorders.
New insights into metabolic and immune pathway interactions in obesity
July 5, 2024 / Metabolic Pathways / Immune Pathways / Obesity / Type 2 Diabetes
Dysregulation of interwoven metabolic and immune pathways contributes to the development of metabolic diseases like obesity and type 2 diabetes, which have become increasingly common globally.
Research Priorities for Non-Communicable Diseases in Humanitarian Crises: Focus on Cardio-Metabolic Syndrome
July 5, 2024 / Non-communicable Diseases / Cardio-metabolic Syndrome / Healthcare
Research priorities highlight the need for evidence-based strategies to address non-communicable diseases, particularly cardio-metabolic syndrome, in humanitarian crises, where NCDs pose a significant health threat.
Superiority of the triglyceride glucose index over the homeostasis model in predicting metabolic syndrome based on NHANES data analysis
July 5, 2024 / TyG Index / Metabolic Syndrome / Insulin Resistance
The triglyceride-glucose (TyG) index outperforms the traditional homeostasis model assessment (HOMA) in predicting metabolic syndrome (MetS), showing higher accuracy in large-scale NHANES data analysis.
Can a compound found in olives help treat obesity and diabetes?
July 4, 2024 / Obesity Treatment / Weight Loss / Blood Sugar Control / Diabetes
A study presented at NUTRITION 2024 suggests that a natural compound in olives may aid in weight loss and improve blood sugar control in obesity and type 2 diabetes.
The cardiometabolic risk of a higher body mass index may be underestimated in taller grown populations worldwide
July 4, 2024 / Cardiometabolic Risk / BMI / Obesity Epidemic / Type 2 Diabetes
Research indicates that taller individuals may have an underestimated cardiometabolic risk associated with higher BMI, suggesting that height should be considered when evaluating obesity-related health risks.
Common food could revolutionise obesity and diabetes treatment, study reveals
July 4, 2024 /Elenolic Acid / Obesity / Weight Loss / Diabetes Management
Research reveals that elenolic acid in olives can significantly reduce blood sugar levels and promote weight loss in obese diabetic mice, potentially leading to safe, affordable treatments for obesity and type 2 diabetes.
Association of modifiable metabolic risk factors and lifestyle with all-cause mortality in patients with hepatocellular carcinoma
July 4, 2024 / Metabolic Risk Factors / Liver Cancer / HCC Patient Outcomes
In hepatocellular carcinoma (HCC) patients, having two or more metabolic risk factors significantly worsens survival rates. Alcohol intake and smoking further increase overall and HCC-specific mortality risks.
Thyroid Disorder Therapy Market – A comprehensive study by Key Players: AstraZeneca, Bayer, Curium Pharma
July 4, 2024 / Thyroid Disorder / Radioactive Iodine Treatment / Market Growth
The thyroid disorder therapy market, featuring major players like AstraZeneca and Bayer, is set to expand due to increasing disease prevalence, awareness, and technological advancements in treatments such as radioactive iodine (I-131) for hyperthyroidism.
White blood cell type identified as important contributor to inflammation in obesity
July 3, 2024 / Obesity / Insulin Resistance / Cancer / Visceral Adipose Tissue
Neutrophils in visceral adipose tissue (VAT) contribute significantly to chronic inflammation, insulin resistance, and cancer survival in obesity, suggesting potential therapeutic targets for inflammatory obesity-related conditions.
The predictive capability of several anthropometric indices for identifying the risk of metabolic syndrome and its components among industrial workers
July 3, 2024 / Metabolic Syndrome / BRI / Industrial Workers Health
A study among industrial workers revealed that the Body Roundness Index (BRI) is the most effective anthropometric indicator for predicting metabolic syndrome (MetS), outperforming BMI, ABSI, and LAP in identifying at-risk individuals.
Doctors may use facial temperature for easy diagnosis of metabolic diseases
July 3, 2024 / Metabolic Disease Detection / AI / Healthcare
Researchers found that specific facial temperature patterns, identified using AI and thermal cameras, correlate with chronic illnesses like diabetes and high blood pressure, aiding in early diagnosis and detection of metabolic diseases.
Sedentary lifestyle and screen time linked to rising metabolic syndrome in Chinese youth
July 2, 2024 /Metabolic Syndrome / Youth / China / Screen Time Impact
A study in BMC Public Health links sedentary lifestyle and increased screen time to rising metabolic syndrome (MetS) among Chinese youth, highlighting the need for interventions to reduce these behaviors to improve long-term health outcomes.
Bariatric and Metabolic Surgery Mortality Reduction Depends on Diabetes Duration
July 2, 2024 / Bariatric Surgery Mortality / Diabetes / GLP-1 / Metabolic Surgery
Bariatric surgery significantly reduces mortality in type 2 diabetes patients with diabetes duration of 10 years or less, compared to GLP-1RAs, with greater reductions in BMI and HbA1c observed over a median follow-up of 6.8 years.